E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/19/2015 in the Prospect News Structured Products Daily.

New Issue: Wells Fargo prices $5.94 million buffered enhanced notes linked to iShares MSCI EM

By Angela McDaniels

Tacoma, Wash., Oct. 19 – Wells Fargo & Co. priced $5.94 million of 0% buffered enhanced return securities with capped upside and buffered downside due Oct. 19, 2017 linked to the iShares MSCI Emerging Markets exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

If the ETF’s final share price is greater than the initial share price, the payout at maturity will be par plus 200% of the ETF return, subject to a maximum settlement amount of $1,252 per $1,000 principal amount of notes. Investors will receive par if the ETF declines by 10% or less and will lose 1.1111% for every 1% that it declines beyond 10%.

Wells Fargo Securities LLC is the agent.

Issuer:Wells Fargo & Co.
Issue:Buffered enhanced return securities with capped upside and buffered downside
Underlying ETF:iShares MSCI Emerging Markets ETF
Amount:$5.94 million
Maturity:Oct. 19, 2017
Coupon:0%
Price:Par
Payout at maturity:If ETF return is positive, par plus 200% of gain, subject to 25.2% maximum return; par if ETF decreases by 10% or less; 1.1111% loss for every 1% that ETF declines beyond 10%
Initial price:$36.22
Threshold price:$32.598, 90% of initial share price
Pricing date:Oct. 15
Settlement date:Oct. 22
Agent:Wells Fargo Securities LLC
Fees:2%
Cusip:94986RZK0

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.